Partners Group Acquires Pharmathen from BC Partners
July 19, 2021
Partners Group has agreed to acquire Pharmathen, the leading European drug delivery technology and pharmaceutical manufacturing company, from BC Partners in a transaction valued at approximately EUR 1.6 billion. The deal transfers control of Pharmathen to Partners Group (acting on behalf of its clients) and is aimed at supporting the company’s continued growth — including an intensified push into the US market — building on strong R&D and manufacturing capabilities.
- Buyers
- Partners Group
- Targets
- Pharmathen
- Sellers
- BC Partners, VNK Capital Ltd
- Industry
- Pharmaceuticals
- Location
- Attica, Greece
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
BC Partners and Bpifrance Acquire Biogaran from Servier
January 30, 2026
Pharmaceuticals
BC Partners and Bpifrance have completed the acquisition of Biogaran from Servier. The deal is supported by regulatory approvals (including EU clearances and French foreign investment screening), after a favourable opinion from Biogaran’s Social and Economic Committee.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
-
GHO Capital and Partners Group Invest in Sterling Pharma Solutions
May 25, 2023
Pharmaceuticals
GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.
-
CGE Partners Invests in Datapharm
February 28, 2022
Pharmaceuticals
CGE Partners has made a growth investment in Datapharm, the UK-based provider of regulatory-driven medicines information and software (including the electronic medicines compendium, emc). The investment will partner with Datapharm's management to accelerate new product development, international expansion, and support strategic acquisitions.
-
Odyssey Investment Partners Acquires ProPharma Group
September 22, 2020
Healthcare Services
Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.
-
Enhanced Healthcare Partners & Bourne Partners Strategic Capital Acquire Pharmaceutical Associates, Inc.
November 6, 2019
Pharmaceuticals
Enhanced Healthcare Partners (EHP), together with Bourne Partners Strategic Capital (BPSC), announced the acquisition of Pharmaceutical Associates, Inc. (PAI), a U.S. manufacturer of generic liquid and unit-dose pharmaceuticals. The investment will provide growth capital to expand PAI's manufacturing capacity, product lines and market footprint while leveraging BPSC's pharmaceutical network and EHP's healthcare investment experience.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.